Company Filing History:
Years Active: 2018-2024
Title: The Innovative Contributions of Mattia Matasci
Introduction
Mattia Matasci is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions and diagnostic tools. With a total of 2 patents to his name, Matasci continues to push the boundaries of innovation in his field.
Latest Patents
Matasci's latest patents include groundbreaking inventions that address critical health issues. The first patent, titled "EDB targeting IL-12 compositions," relates to compositions comprising an interleukin-12 (IL-12) protein that includes a first and second subunit, an extra domain B (ED-B)-binding domain, and a linker connecting the IL-12 protein to the ED-B-binding domain. This invention has the potential to enhance therapeutic strategies for various diseases. The second patent, "Antibodies for treatment and diagnosis," focuses on the diagnosis and treatment of diseases, including cancer and inflammatory disorders. This invention provides antibodies that bind to specific targets, including the IIICS isoform of fibronectin, matrix-metalloproteinase 3 (MMP3), periostin, and tenascin-W.
Career Highlights
Matasci is currently associated with Philogen S.p.a., a company known for its innovative approaches in the field of biopharmaceuticals. His work at Philogen has allowed him to collaborate with leading experts and contribute to the advancement of medical science.
Collaborations
One of Matasci's notable collaborators is Tiziano Ongaro. Their partnership exemplifies the collaborative spirit that drives innovation in the biotechnology sector.
Conclusion
Mattia Matasci's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in treatment and diagnosis, making a significant impact on healthcare.